According to Cocrystal Pharma 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.52. At the end of 2024 the company had a P/S ratio of N/A.
Year | P/S ratio | Change |
---|---|---|
2024 | N/A | |
2023 | N/A | |
2022 | N/A | |
2021 | N/A | -100% |
2020 | 46.3 | 1644.91% |
2019 | 2.65 | |
2018 | N/A | |
2017 | N/A | |
2016 | N/A | -100% |
2015 | > 1000 | 38.61% |
2014 | > 1000 | |
2013 | N/A | -100% |
2012 | 12.0 | -37.67% |
2011 | 19.3 | |
2009 | N/A |